Transcom Instruments(BJ:831961)2022-10-29 02:18Group 1: Market Trends and Company Positioning - The trend of domestic market substitution for high-end wireless communication testing instruments is expected to grow significantly in the coming years due to the increasing enthusiasm for domestic products among downstream customers [4] - The company has invested a total of 378,920,016.35 CNY in R&D over the past three years, accounting for 40.06% of its revenue, indicating a strong commitment to enhancing core competitiveness [5] Group 2: Financial Performance - For Q3 2022, the company reported a revenue of 78,761,988.62 CNY, a decrease of 13.62% year-on-year, and a net profit of 5,732,273.23 CNY, down 30.05% year-on-year, primarily due to the impact of the pandemic [6] - R&D expenditures for the first nine months of 2022 amounted to 142,463,838.90 CNY, representing 66.20% of revenue, which is an increase of 52.14% compared to the previous year [5] Group 3: Impact of COVID-19 - The ongoing pandemic continues to affect the company, with temporary lockdowns impacting employee operations and sales activities, although efforts to expand sales channels are being maintained [7] Group 4: Share Repurchase and Future Plans - The company has completed its share repurchase plan, acquiring 1,513,803 shares, which is 1.06% of the total share capital, for a total payment of 19,442,441.89 CNY, with plans to use these shares for employee equity incentives [8] Group 5: Government Policies and Industry Impact - Recent government policies, including a 200 billion CNY special loan for equipment upgrades at a low interest rate, are expected to stimulate demand for testing instruments, benefiting both manufacturers and users [9]